Know More About “Medical Specimen Tracking System Market 2022-2030” Growth Worldwide…Posted by Mrudula Anil Karmarkar on November 16th, 2023 San Francisco, 16 November 2023: The ReportMedical Specimen Tracking System Market Size, Share & Trends Analysis Report By Product (Software, Consumables), By Technology (Barcode, RFID), By Type, By End User, By Region, And Segment Forecasts, 2022 - 2030 The global medical specimen tracking system market size is anticipated to reach USD 1.77 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to grow at a lucrative CAGR of 10.3% from 2022 to 2030. The key factors driving the market growth include the technological advancements by market players and increasing product adoption for reducing errors in patient diagnosis. Before the COVID-19 pandemic, the adoption of specimen tracking solutions was less. However, due to the pandemic, the demand for these systems skyrocketed, which positively influenced the market growth. Most market players, such as Labcorp Drug Development, Agilent Technologies, and Thermo Fisher Scientific, experienced positive growth from 2022 to 2020 in their segment-specific revenues as well as annual revenues. For instance, Labcorp Drug Development experienced 21% growth and Thermo Fisher Scientific experienced 26.1% growth from 2022 to 2020. On the other hand, Zebra Technologies Corp. experienced a decline of 3.6% in its Asset, Intelligence, & Tracking segment’s revenue and a 0.8% decline in its annual revenue from 2022 to 2020. Therefore, the overall market was not negatively impacted due to the pandemic. Using barcoding and tracking systems for specimen testing decreases the incidence of errors. According to GA International, the adoption of a medical specimen tracking system reduced the number of errors from 11 to 14 slides out of 10,000 to 0-1 out of 10,000 in the Department of Pathology, University Hospitals Case Medical Center, Cleveland, Ohio. The study also demonstrated that a 62% reduction in case misidentification was reported in Henry Ford Hospital, Detroit, Michigan, U.S. These factors are anticipated to increase the product adoption, thereby boosting the market growth. Many companies specializing in medical specimen tracking systems hold a significant share of the market. Key players are involved in increasing their market share through R&D, product launches, geographical expansions, partnerships, and other strategies. For example, in November 2020, TrakCel completed the proof-of-concept phase for its technology integration with U.K. NHS partners. The project is part of the development of the MW-ATTC initiative and is funded by the U.K.’s public innovation agency to facilitate the integration of orchestration software into pan-national healthcare IT systems. Favorable government regulations coupled with the rising adoption of specimen tracking systems for reducing errors in patient diagnosis are some of the key drivers of this market. According to Leica BioSystems, around 98,000 people die every year in U.S. hospitals & clinics owing to misdiagnosis. Furthermore, untapped opportunities in various emerging countries are anticipated to provide opportunities for market players to invest in the market. During the COVID-19 pandemic, the adoption of these systems increased owing to quicker as well as correct diagnosis of the samples. Request sample report of Medical Specimen Tracking System Market@https://www.grandviewresearch.com/industry-analysis/medical-specimen-tracking-system-market-report/request/rs1 Furthermore, their use was also increased to reduce the misdiagnosis of the disease and to avoid the false positive COVID-19 results. Also, globally, laboratories were challenged by the sudden surge in the sample test numbers, as they had to reliably track the suspected COVID-19 patient swabs to 2D-coded tubes and then to racks of 96 tubes. This also increased the product demand, thereby positively influencing the market growth during the pandemic. Various medical errors are caused due to sampling mislabeling, which leads to patient misdiagnosis. According to Leica Biosystems Nussloch GmbH, about 4 out of every 1,000 surgical specimens lead to patient identification errors. Medical Specimen Tracking System Market Report Highlights
Also, 2 out of every 1,000 medical reports do not reach the correct patient and 1 out of every 1,000 such cases are affected due to mislabeling. Such medical errors result in the growing demand for medical specimen tracking systems, thereby fueling the market growth. The arrival of specimens on time is very important because delays can lead to a variety of challenges, which jeopardizes customer satisfaction. Not using these systems might result in the delivery of specimens to the wrong lab. Using these systems results in speeding up the productivity of labs. Furthermore, benefits, such as reduction in missing or losing specimens, cost-effectiveness, reduction in turnaround time leading to increased revenue, and improved quality of care, are also some of the factors boosting the market growth. Medical Specimen Tracking System Market Report Scope
The global market is highly competitive. Key companies deploy strategic initiatives, such as product development and launches, sales & marketing strategies to increase product awareness, regional expansion, and partnerships to gain a higher market share. For instance, in May 2021, TrakCel partnered with BarTender. The company will integrate the BarTender barcode and labeling solution within OCELLOS by TrakCel. OCELLOS has been developed for cell and gene therapy manufacturers. List of Key Players of the Medical Specimen Tracking System Market
Like it? Share it! More by this author |